SCHEMBL29633829

SCHEMBL29633829

COc1ccc(CCC(C(=O)OC(C)(C)C)N(C)C(=O)OCC2c3ccccc3-c3ccccc32)cn1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FABP5 Q01469 2/20 0.36
MDM2 Q00987 2/20 0.33
ACACB O00763 1/20 0.33
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
TAS2R14 Q9NYV8 1/20 0.32
EPHX2 P34913 1/20 0.32
CHRM1 P11229 1/20 0.31
KMT2A Q03164 2/20 0.31
BRS3 P32247 1/20 0.31
MDM4 O15151 1/20 0.31
TP53 P04637 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
PKM P14618 1/20 0.31
MEN1 O00255 1/20 0.31
FABP7 O15540 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25657534 0.91 FABP5 (0.37) FABP5MDM2TAS2R14CHRM1KMT2A
SCHEMBL29633905 0.91 FABP5 (0.37) FABP5MDM2TAS2R14CHRM1KMT2A
SCHEMBL29633804 0.90 FABP5 (0.33) FABP5MDM2EPHX2KMT2AMDM4
SCHEMBL25357875 0.89 FABP5 (0.40) FABP5MDM2ACACBCACNA1GCACNA1H
SCHEMBL25357871 0.89 FABP5 (0.40) FABP5MDM2ACACBCACNA1GCACNA1H
SCHEMBL29633807 0.89 FABP5 (0.40) FABP5MDM2ACACBCACNA1GCACNA1H
SCHEMBL29633784 0.87 MDM2 (0.37) FABP5MDM2EPHX2
SCHEMBL29633761 0.85 FABP5 (0.38) FABP5MDM2EPHX2KMT2AFABP7
SCHEMBL22454857 0.85 CYP3A4 (0.35) MDM2CHRM1LMNA
SCHEMBL29633809 0.85 CYP3A4 (0.35) MDM2CHRM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885MDM2 223/4885ACACB 999/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885MDM2 223/4885ACACB 999/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR FABP5 608/4885MDM2 223/4885ACACB 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.